{"id":8804,"date":"2019-06-21T16:42:33","date_gmt":"2019-06-21T20:42:33","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=8804"},"modified":"2019-06-22T15:06:59","modified_gmt":"2019-06-22T19:06:59","slug":"06-17-19-06-21-19-ipo-summary","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/06-17-19-06-21-19-ipo-summary\/","title":{"rendered":"06\/17\/19-06\/21\/19 IPO Summary"},"content":{"rendered":"<p><!--more--><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-8805 size-full\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary.jpg\" alt=\"\" width=\"1329\" height=\"314\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary.jpg 1329w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary-600x142.jpg 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary-300x71.jpg 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary-768x181.jpg 768w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/iposummary-1024x242.jpg 1024w\" sizes=\"(max-width: 1329px) 100vw, 1329px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The first of two biotech heavy weeks was overwhelmingly positive with strong gains coming from four-of-the five deals to debut. <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.55.59-AM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-8696\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.55.59-AM-300x139.png\" alt=\"\" width=\"300\" height=\"139\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.55.59-AM-300x139.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.55.59-AM.png 357w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>Stoke Therapeutics (STOK) <\/b><span style=\"font-weight: 400;\">priced an upsized offering of 7.89mm shares \u00a0(originally 6.7mm) at $18.00 ($2.00 above range) and opened at $27.21 for a gain of 51.2% at first trade. STOK hit a high of $30.14 on its opening day of trading.<\/span><\/p>\n<p><em><strong>FREEBIE:<\/strong> What did IPO Boutique paying clients know about Stoke Therapeutics leading up to its highly-lucrative debut? (<a href=\"http:\/\/www.ipoboutique.com\/blog\/ipo-boutique-comments-on-stoke-therapeutics-inc-stok\/\"><strong>CLICK HERE FOR PREMIUM CONTENT<\/strong><\/a>)<\/em><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.39.48-AM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-8692\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.39.48-AM-300x68.png\" alt=\"\" width=\"300\" height=\"68\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.39.48-AM-300x68.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.39.48-AM.png 495w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>Personalis Inc (PSNL) <\/b><span style=\"font-weight: 400;\">priced an upsized deal, 7.92mm shares (up from 6.7mm), at \u00a0$17.00 ($1.00 above range), and<\/span><b> opened at $23.70 for a gain of 39.4% at first trade. PSNL traded as high as $29.50<\/b><span style=\"font-weight: 400;\"> in its opening day of trading<\/span><b>.<\/b><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.20.28-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8705\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.20.28-AM-300x98.png\" alt=\"\" width=\"300\" height=\"98\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.20.28-AM-300x98.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.20.28-AM.png 415w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b> Akero Therapeutics (AKRO)<\/b><span style=\"font-weight: 400;\"> priced an upsized offering of 5.75mm shares (5.0mm original size) at the high end of the range, $16.00 and opened at $16.16 for a 1.0% gain at first trade. AKRO traded very well in the aftermarket and hit a high of $21.94 for a gain of 37.1% at top tick. <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.06.44-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-8701\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-11.06.44-AM.png\" alt=\"\" width=\"205\" height=\"182\" \/><\/a><\/p>\n<p><b>Atreca Inc. (BCEL)<\/b><span style=\"font-weight: 400;\"> priced a full-size deal, 7.35mm shares, at the midpoint of the range, $17.00, and opened at $19.90 for a gain of 17.1% at first trade. The stock faced immediate selling pressure and broke the issue price within the first ten minutes of trading.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.01.58-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-8684\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.01.58-AM.png\" alt=\"\" width=\"198\" height=\"69\" \/><\/a><\/p>\n<p><b>Prevail Therapeutics (PRVL) <\/b><span style=\"font-weight: 400;\">priced a full-size deal at the midpoint of the range, $17.00, and opened at $15.31 for a loss of 9.9% at first trade. PRVL was under <\/span><b>heavy<\/b><span style=\"font-weight: 400;\"> selling pressure on day one. This \u201cmay\u201d have been due to a litigation issue released in a FWP (free-writing prospectus) that was issued the day prior to debut that \u201cmay\u201d have scared investors away.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.19.25-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8688\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.19.25-AM-300x68.png\" alt=\"\" width=\"300\" height=\"68\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.19.25-AM-300x68.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-10.19.25-AM.png 500w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">It should be noted that one biotech that was scheduled to debut, <\/span><b>Dermavant Sciences (DRMT)<\/b><span style=\"font-weight: 400;\"> was postponed. The parent company, Roivant Sciences, elected to pull the deal and there is no further information at this time.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-9.39.18-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8679\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-9.39.18-AM-300x77.png\" alt=\"\" width=\"300\" height=\"77\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-9.39.18-AM-300x77.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-17-at-9.39.18-AM.png 313w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">As for the non-bio syndicate transaction, <\/span><b>Grocery Outlet Holding Corp (GO)<\/b><span style=\"font-weight: 400;\">&#8230;.the IPO priced a full-size deal at $22.00 ($5.00 above the original $15-$17 range) and opened at $31.00 for a gain of 40.9% at first trade. \u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The highly-publicized direct listing,<\/span><b> Slack Inc (WORK)<\/b><span style=\"font-weight: 400;\">, set a reference price of $26.00, however the opening price (which will also be the initial public offering price for those tracking this at home) is $38.50. As of 11am ET on Friday, WORK was trading right around $38.25.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[1836,1837,1838,1839,1841,1840,1843,1842],"class_list":["post-8804","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content","tag-akro","tag-bcel","tag-drmt","tag-go","tag-prvl","tag-psnl","tag-stok","tag-work"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=8804"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8804\/revisions"}],"predecessor-version":[{"id":8816,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8804\/revisions\/8816"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=8804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=8804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=8804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}